Several of these C-clamp-specific targets are inhibitors of p21 (e.g., SP5, TGIF, YAP1), suggesting a model where C-clamp containing TCF activates their expression to bypass a p21 block in the cell cycle of CRC cells [49]. The gene discussed is SP5; the disease is colorectal carcinoma.